Publications of Reinhard Hohlfeld

Hohlfeld, R.: Immunologic factors in primary progressive multiple sclerosis. Multiple Sclerosis 10, pp. 16 - 22 (2004)

Hohlfeld, R.; Wekerle, H.: Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines. Proceedings of the National Academy of Sciences of the United States of America 101 (Suppl. Suppl. 2), pp. 14599 - 14606 (2004)

Neuhaus, O.; Kieseier, B. C.; Klimke, A.; Gaebel, W.; Hohlfeld, R.; Hartung, H. P.: Cannabinoids in multiple sclerosis. Opportunity or threat? Nervenarzt 75 (10), pp. 1022 - 1026 (2004)

Pellkofer, H.; Schubart, A. S.; Hoftberger, R.; Schutze, N.; Pagany, M.; Schuller, M.; Lassmann, H.; Hohlfeld, R.; Voltz, R.; Linington, C.: Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 127, pp. 1822 - 1830 (2004)

Skulina, C.; Schmidt, S.; Dornmair, K.; Babbe, H.; Roers, A.; Rajewsky, K.; Wekerle, H.; Hohlfeld, R.; Goebels, N.: Multiple sclerosis: Brain-infiltrating CD8(+) T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proceedings of the National Academy of Sciences of the United States of America 101 (8), pp. 2428 - 2433 (2004)

Weber, M. S.; Starck, M.; Wagenpfeil, S.; Meinl, E.; Hohlfeld, R.; Farina, C.: Multiple sclerosis: Glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 127, pp. 1370 - 1378 (2004)

Bradl, M.; Hohlfeld, R.: Neuroscience for Neurologists: Molecular pathogenesis of neuroinflammation. Journal of Neurology, Neurosurgery and Psychiatry 74, pp. 1364 - 1370 (2003)

Dalakas, M. C.; Hohlfeld, R.: Diagnostic criteria for polymyositis and dermatomyositis - Reply. Lancet 362 (9397), p. 1763 - 1763 (2003)

Dalakas, M. C.; Hohlfeld, R.: Polymyositis and dermatomyositis. Lancet 362 (9388), pp. 971 - 982 (2003)

Dornmair, K.; Goebels, N.; Weltzien, H. U.; Wekerle, H.; Hohlfeld, R.: T-cell-mediated autoimmunity - Novel techniques to characterize autoreactive T-cell receptors. American Journal of Pathology 163 (4), pp. 1215 - 1226 (2003)

Hohlfeld, R.: Hunting (auto)immune T cells in neuroimmunological diseases. Brain 126, pp. 2 - 4 (2003)

Hohlfeld, R.: The prospects for neuroprotection in MS. International MS Journal 10, pp. 103 - 105 (2003)

Hohlfeld, R.; Dalakas, M.: Basic principles of immunotherapy for neurologic diseases. Seminars in Neurology 23, pp. 121 - 131 (2003)

Kerschensteiner, M.; Hohlfeld, R.: Neurotrophic factors protect myelin from attack. International MS Journal 10 (1), pp. 2 - 4 (2003)

Kerschensteiner, M.; Stadelmann, C.; Dechant, G.; Wekerle, H.; Hohlfeld, R.: Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Annals of Neurology 53 (3), pp. 292 - 304 (2003)

Voltz, R.; Albrich, W.; Hohlfeld, R.; Nagel, D.; Wick, M.; Kirchner, T.; Sommer, N.; Illa, I.; Kaminski, H.; Schumm, F.: Anti-titin antibodies are not associatd with a specific thymoma histology. Journal of Neurology, Neurosurgery and Psychiatry 74, p. 282 - 282 (2003)

Wekerle, H.; Hohlfeld, R.: Molecular mimicry in multiple sclerosis. New England Journal of Medicine 349 (2), pp. 185 - 186 (2003)

Wiendl, H.; Mitsdörfer, M.; Hofmeister, V.; Wischhusen, J.; Weiss, E. H.; Dichgans, J.; Lochmüller, H.; Hohlfeld, R.; Melms, A.; Weller, M.: The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: Implications for myoblast transplnatation and gene therapy. Brain 126, pp. 176 - 185 (2003)

Clanet, M.; Radue, E. W.; Kappos, L.; Hartung, H. P.; Hohlfeld, R.; Sandberg-Wollheim, M.; Kooijmans-Coutinho, M. F.; Tsao, E. C.; Sandrock, A. W.; European IFNß-1a (Avonex) Dose-Comparison Study Investigators: A randomised, double-blind, dose-comparison study of weekly interferon ß-1a in relapsing MS. Neurology 59 (10), pp. 1507 - 1517 (2002)

Farina, C.; Vargas-Leal, V.; Heydari, N.; Kümpfel, T.; Meinl, E.; Hohlfeld, R.: Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients. Journal of Neuroimmunology 123 (1-2), pp. 188 - 192 (2002)